| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | [NPHE1]NOCICEPTIN(1-13)NH2 Basic information |
| | [NPHE1]NOCICEPTIN(1-13)NH2 Chemical Properties |
| density | 1.44±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | solubility | Soluble to 1 mg/ml in 10% acetonitrile | | form | lyophilized powder | | pka | 12.91±0.46(Predicted) |
| | [NPHE1]NOCICEPTIN(1-13)NH2 Usage And Synthesis |
| Uses | [Nphe1]Nociceptin(1-13)NH2, a novel nociceptin/orphanin FQ (NC) endogenous ligand, is a selective and competitive ociceptin receptor antagonist without any residual agonist activity. [Nphe1]nociceptin(1-13)NH2binds selectively to recombinant nociceptin receptors (pKi=8.4) and antagonizes the inhibitory effects of nociceptin on cyclic AMP accumulation in CHO cells (pA2=6.0). [Nphe1]Nociceptin(1-13)NH2 has the potential to act as an analgesic agent[1]. | | References | [1] Y Hashimoto, et al. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor DOI:10.1016/s0304-3940(99)00915-5 [2] G Calo', et al. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol.2000 Mar;129(6):1183-93. DOI:10.1038/sj.bjp.0703169 |
| | [NPHE1]NOCICEPTIN(1-13)NH2 Preparation Products And Raw materials |
|